Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Therapeutic Drug Monitoring
|
July 16, 2019
Determination of Cetuximab in Plasma by Liquid Chromatography-High-Resolution Mass Spectrometry Orbitrap With a Stable Labeled 13C,15N-Cetuximab Internal Standard
Aurélien Millet, Dorothée Lebert, Guillaume Picard, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
September 30, 2022
Quantification of canakinumab in human plasma by liquid chromatography-high resolution mass spectrometry
Aurélien Millet, Rémi Pescarmona, Alexandre Belot, et al.
Therapeutic Drug Monitoring
|
February 2, 2023
Evaluation of Limited Sampling Strategies for Bayesian Estimation of Daptomycin Area Under the Concentration-Time Curve: A Short Communication
Vianney Tuloup, Aurélien Millet, Alessandra Taricco, et al.
Molecules (Basel, Switzerland)
|
April 3, 2021
Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma
Aurélien Millet, Nihel Khoudour, Dorothée Lebert, et al.
Clinical Pharmacokinetics
|
January 27, 2025
Exposure to Rifampicin and its Metabolite 25-Deacetylrifampicin Rapidly Decreases During Tuberculosis Therapy
Sylvain Goutelle, Olivier Bahuaud, Charlotte Genestet, et al.
Biomedicines
|
June 2, 2021
Analysis of Pembrolizumab in Human Plasma by LC-MS/HRMS. Method Validation and Comparison with Elisa
Aurélien Millet, Nihel Khoudour, Jérôme Guitton, et al.
Antimicrobial Agents and Chemotherapy
|
November 7, 2025
Risk factors of daptomycin overexposure: a case-control study
Clotilde Vellat, Romain Garreau, Aurélien Millet, et al.
The Journal of Antimicrobial Chemotherapy
|
January 15, 2025
Navigating the complexities of azole antifungal therapy through pharmacokinetic concepts: a case of prolonged isavuconazole toxicity
Manon Launay, Florian Saunier, Sarah Baklouti, et al.
Rheumatology (Oxford, England)
|
March 24, 2022
Safety of canakinumab during pregnancy: seven new cases
Emmanuelle Weber, Aurélien Millet, Delphine Beghin, et al.
Talanta
|
December 31, 2020
Quantification of nivolumab in human plasma by LC-MS/HRMS and LC-MS/MS, comparison with ELISA
Aurélien Millet, Nihel Khoudour, Pauline Bros, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Therapeutic Drug Monitoring
|
July 16, 2019
Determination of Cetuximab in Plasma by Liquid Chromatography-High-Resolution Mass Spectrometry Orbitrap With a Stable Labeled 13C,15N-Cetuximab Internal Standard
Aurélien Millet, Dorothée Lebert, Guillaume Picard, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
September 30, 2022
Quantification of canakinumab in human plasma by liquid chromatography-high resolution mass spectrometry
Aurélien Millet, Rémi Pescarmona, Alexandre Belot, et al.
Therapeutic Drug Monitoring
|
February 2, 2023
Evaluation of Limited Sampling Strategies for Bayesian Estimation of Daptomycin Area Under the Concentration-Time Curve: A Short Communication
Vianney Tuloup, Aurélien Millet, Alessandra Taricco, et al.
Molecules (Basel, Switzerland)
|
April 3, 2021
Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma
Aurélien Millet, Nihel Khoudour, Dorothée Lebert, et al.
Clinical Pharmacokinetics
|
January 27, 2025
Exposure to Rifampicin and its Metabolite 25-Deacetylrifampicin Rapidly Decreases During Tuberculosis Therapy
Sylvain Goutelle, Olivier Bahuaud, Charlotte Genestet, et al.
Biomedicines
|
June 2, 2021
Analysis of Pembrolizumab in Human Plasma by LC-MS/HRMS. Method Validation and Comparison with Elisa
Aurélien Millet, Nihel Khoudour, Jérôme Guitton, et al.
Antimicrobial Agents and Chemotherapy
|
November 7, 2025
Risk factors of daptomycin overexposure: a case-control study
Clotilde Vellat, Romain Garreau, Aurélien Millet, et al.
The Journal of Antimicrobial Chemotherapy
|
January 15, 2025
Navigating the complexities of azole antifungal therapy through pharmacokinetic concepts: a case of prolonged isavuconazole toxicity
Manon Launay, Florian Saunier, Sarah Baklouti, et al.
Rheumatology (Oxford, England)
|
March 24, 2022
Safety of canakinumab during pregnancy: seven new cases
Emmanuelle Weber, Aurélien Millet, Delphine Beghin, et al.
Talanta
|
December 31, 2020
Quantification of nivolumab in human plasma by LC-MS/HRMS and LC-MS/MS, comparison with ELISA
Aurélien Millet, Nihel Khoudour, Pauline Bros, et al.
Page
of 2